21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010–2013 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-03-23

AUTHORS

Julie A. Lynch, Brygida Berse, Nicole Coomer, John Kautter

ABSTRACT

Purpose:We evaluated national patient-level utilization of the 21-gene recurrence score (21-gene RS) test among Medicare beneficiaries with breast cancer. We analyzed clinical, demographic, and regional factors that predict testing.Methods:Using 2010–2013 Medicare claims, we conducted a retrospective study of breast cancer patients. The outcome variable was whether the patient underwent testing. Independent variables expected to predict testing were age, gender, race, Medicaid status, clinical characteristics, and hospital referral region (HRR).Results:From 2010 to 2013, the number of test orders increased by 23.0%. Of the 256,818 patients identified in 2011–2012 claims, 25,352 (9.9%) underwent the 21-gene RS test. Estrogen receptor–positive status was the strongest positive predictor of testing (odds ratio (OR) 2.58, 95% confidence interval (CI) 2.48–2.69). White patients were more likely to be tested than minorities (OR 1.46, 95% CI 1.39–1.52). Secondary cancer was the strongest negative predictor. Medicaid recipients were less likely to be tested (OR 0.74, 95% CI 0.71–0.78). The likelihood of testing decreased with increasing age and comorbidities.Conclusions:Despite widespread implementation of the 21-gene RS test, minorities and Medicaid recipients had less access to testing. Many patients with serious comorbidities or advanced age were tested even though the risk algorithm may not have been applicable to them.Genet Med advance online publication 23 March 2017 More... »

PAGES

1134-1143

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/gim.2017.19

DOI

http://dx.doi.org/10.1038/gim.2017.19

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084128065

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28333918


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Profiling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Testing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medicare", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA", 
          "id": "http://www.grid.ac/institutes/grid.280807.5", 
          "name": [
            "RTI International, Waltham, Massachusetts, USA", 
            "Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lynch", 
        "givenName": "Julie A.", 
        "id": "sg:person.0674353541.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674353541.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Veterans Health Administration, Bedford, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.413726.5", 
          "name": [
            "RTI International, Waltham, Massachusetts, USA", 
            "Boston University School of Medicine, Boston, Massachusetts, USA", 
            "Veterans Health Administration, Bedford, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berse", 
        "givenName": "Brygida", 
        "id": "sg:person.01167017526.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167017526.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RTI International, Research Triangle Park, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "RTI International, Research Triangle Park, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coomer", 
        "givenName": "Nicole", 
        "id": "sg:person.01245414340.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245414340.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RTI International, Waltham, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "RTI International, Waltham, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kautter", 
        "givenName": "John", 
        "id": "sg:person.0767710632.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767710632.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10549-010-1329-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015355504", 
          "https://doi.org/10.1007/s10549-010-1329-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-013-0115-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036735183", 
          "https://doi.org/10.1007/s40273-013-0115-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/gim.2013.5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051257040", 
          "https://doi.org/10.1038/gim.2013.5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2013.36", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041911179", 
          "https://doi.org/10.1038/modpathol.2013.36"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/gim.2012.119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003414597", 
          "https://doi.org/10.1038/gim.2012.119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2008.54", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020816631", 
          "https://doi.org/10.1038/modpathol.2008.54"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-03-23", 
    "datePublishedReg": "2017-03-23", 
    "description": "Purpose:We evaluated national patient-level utilization of the 21-gene recurrence score (21-gene RS) test among Medicare beneficiaries with breast cancer. We analyzed clinical, demographic, and regional factors that predict testing.Methods:Using 2010\u20132013 Medicare claims, we conducted a retrospective study of breast cancer patients. The outcome variable was whether the patient underwent testing. Independent variables expected to predict testing were age, gender, race, Medicaid status, clinical characteristics, and hospital referral region (HRR).Results:From 2010 to 2013, the number of test orders increased by 23.0%. Of the 256,818 patients identified in 2011\u20132012 claims, 25,352 (9.9%) underwent the 21-gene RS test. Estrogen receptor\u2013positive status was the strongest positive predictor of testing (odds ratio (OR) 2.58, 95% confidence interval (CI) 2.48\u20132.69). White patients were more likely to be tested than minorities (OR 1.46, 95% CI 1.39\u20131.52). Secondary cancer was the strongest negative predictor. Medicaid recipients were less likely to be tested (OR 0.74, 95% CI 0.71\u20130.78). The likelihood of testing decreased with increasing age and comorbidities.Conclusions:Despite widespread implementation of the 21-gene RS test, minorities and Medicaid recipients had less access to testing. Many patients with serious comorbidities or advanced age were tested even though the risk algorithm may not have been applicable to them.Genet Med advance online publication 23 March 2017", 
    "genre": "article", 
    "id": "sg:pub.10.1038/gim.2017.19", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1119411", 
        "issn": [
          "1098-3600", 
          "1530-0366"
        ], 
        "name": "Genetics in Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "hospital referral regions", 
      "breast cancer", 
      "Medicaid recipients", 
      "Medicare beneficiaries", 
      "estrogen receptor-positive status", 
      "Recurrence Score test", 
      "breast cancer patients", 
      "likelihood of testing", 
      "serious comorbidities", 
      "clinical characteristics", 
      "white patients", 
      "retrospective study", 
      "Medicaid status", 
      "cancer patients", 
      "strong negative predictor", 
      "recurrence score", 
      "underwent testing", 
      "advanced age", 
      "secondary cancers", 
      "Medicare claims", 
      "referral regions", 
      "risk algorithm", 
      "patients", 
      "outcome variables", 
      "negative predictor", 
      "cancer", 
      "comorbidities", 
      "age", 
      "strong positive predictor", 
      "positive predictor", 
      "recipients", 
      "test order", 
      "RS test", 
      "widespread implementation", 
      "less access", 
      "predictors", 
      "status", 
      "testing", 
      "minority", 
      "test", 
      "scores", 
      "beneficiaries", 
      "independent variables", 
      "gender", 
      "factors", 
      "race", 
      "study", 
      "variables", 
      "likelihood", 
      "score test", 
      "access", 
      "number", 
      "utilization", 
      "characteristics", 
      "regional factors", 
      "region", 
      "claims", 
      "order", 
      "implementation", 
      "algorithm", 
      "national patient-level utilization", 
      "patient-level utilization", 
      "patient underwent testing", 
      "receptor\u2013positive status"
    ], 
    "name": "21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010\u20132013", 
    "pagination": "1134-1143", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084128065"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/gim.2017.19"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28333918"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/gim.2017.19", 
      "https://app.dimensions.ai/details/publication/pub.1084128065"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_744.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/gim.2017.19"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/gim.2017.19'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/gim.2017.19'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/gim.2017.19'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/gim.2017.19'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      22 PREDICATES      113 URIs      99 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/gim.2017.19 schema:about N014e2618a2734a349c51c8da8ccebb58
2 N0642134fa6964d0dbad354f78a21fe9c
3 N06c399cd7eb145c5808344c5429fbe9d
4 N08db4848e85149c4b2ebc093e9b3d5f5
5 N0bea61972b6b4b4fbea0cb3cb47622bc
6 N0c031f92ebff4a298f40613dbab562ea
7 N15391e8e591647f0b5353e0257fd5345
8 N1a126eec81304c31bf94233379749de0
9 N619c3648d92b4aef93196859ce3fe0c1
10 N6311666e3b7b49ec855e86b25c095ea7
11 N76617ae20b144583b9fca89f561eafdf
12 N8e10de17f7204cfbb7051ed8648ec228
13 N9164c9593d4d4f93851a363210c09158
14 Na263edbd94e94afb8a680e79a0f93b72
15 Naccdd8f349a8425886bc389d954f580f
16 Nd27cd223523b469694164a8e5de712ee
17 Nfa1d077c374e435bb36bc9cdf91b0c83
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author N47967678f3f34b9bae432d9669f9d63b
21 schema:citation sg:pub.10.1007/s10549-010-1329-6
22 sg:pub.10.1007/s40273-013-0115-9
23 sg:pub.10.1038/gim.2012.119
24 sg:pub.10.1038/gim.2013.5
25 sg:pub.10.1038/modpathol.2008.54
26 sg:pub.10.1038/modpathol.2013.36
27 schema:datePublished 2017-03-23
28 schema:datePublishedReg 2017-03-23
29 schema:description Purpose:We evaluated national patient-level utilization of the 21-gene recurrence score (21-gene RS) test among Medicare beneficiaries with breast cancer. We analyzed clinical, demographic, and regional factors that predict testing.Methods:Using 2010–2013 Medicare claims, we conducted a retrospective study of breast cancer patients. The outcome variable was whether the patient underwent testing. Independent variables expected to predict testing were age, gender, race, Medicaid status, clinical characteristics, and hospital referral region (HRR).Results:From 2010 to 2013, the number of test orders increased by 23.0%. Of the 256,818 patients identified in 2011–2012 claims, 25,352 (9.9%) underwent the 21-gene RS test. Estrogen receptor–positive status was the strongest positive predictor of testing (odds ratio (OR) 2.58, 95% confidence interval (CI) 2.48–2.69). White patients were more likely to be tested than minorities (OR 1.46, 95% CI 1.39–1.52). Secondary cancer was the strongest negative predictor. Medicaid recipients were less likely to be tested (OR 0.74, 95% CI 0.71–0.78). The likelihood of testing decreased with increasing age and comorbidities.Conclusions:Despite widespread implementation of the 21-gene RS test, minorities and Medicaid recipients had less access to testing. Many patients with serious comorbidities or advanced age were tested even though the risk algorithm may not have been applicable to them.Genet Med advance online publication 23 March 2017
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf N08abc022d1f241209c8e0b6135b11eff
34 N30a8934164b042269a455c88228f9320
35 sg:journal.1119411
36 schema:keywords Medicaid recipients
37 Medicaid status
38 Medicare beneficiaries
39 Medicare claims
40 RS test
41 Recurrence Score test
42 access
43 advanced age
44 age
45 algorithm
46 beneficiaries
47 breast cancer
48 breast cancer patients
49 cancer
50 cancer patients
51 characteristics
52 claims
53 clinical characteristics
54 comorbidities
55 estrogen receptor-positive status
56 factors
57 gender
58 hospital referral regions
59 implementation
60 independent variables
61 less access
62 likelihood
63 likelihood of testing
64 minority
65 national patient-level utilization
66 negative predictor
67 number
68 order
69 outcome variables
70 patient underwent testing
71 patient-level utilization
72 patients
73 positive predictor
74 predictors
75 race
76 receptor–positive status
77 recipients
78 recurrence score
79 referral regions
80 region
81 regional factors
82 retrospective study
83 risk algorithm
84 score test
85 scores
86 secondary cancers
87 serious comorbidities
88 status
89 strong negative predictor
90 strong positive predictor
91 study
92 test
93 test order
94 testing
95 underwent testing
96 utilization
97 variables
98 white patients
99 widespread implementation
100 schema:name 21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010–2013
101 schema:pagination 1134-1143
102 schema:productId N2cdbd95850df4ab094c7592ad788489c
103 N9a845df2ac0944c8bc15e1252f65dbf2
104 Nbea1ece1976f46c2be2009090488f163
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084128065
106 https://doi.org/10.1038/gim.2017.19
107 schema:sdDatePublished 2021-12-01T19:40
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N09f6476b471f4c4dae176788bcf59be5
110 schema:url https://doi.org/10.1038/gim.2017.19
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N014e2618a2734a349c51c8da8ccebb58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Neoplasm Recurrence, Local
116 rdf:type schema:DefinedTerm
117 N0642134fa6964d0dbad354f78a21fe9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Breast Neoplasms
119 rdf:type schema:DefinedTerm
120 N06c399cd7eb145c5808344c5429fbe9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Treatment Outcome
122 rdf:type schema:DefinedTerm
123 N08abc022d1f241209c8e0b6135b11eff schema:issueNumber 10
124 rdf:type schema:PublicationIssue
125 N08db4848e85149c4b2ebc093e9b3d5f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Genetic Testing
127 rdf:type schema:DefinedTerm
128 N09f6476b471f4c4dae176788bcf59be5 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N0bea61972b6b4b4fbea0cb3cb47622bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Middle Aged
132 rdf:type schema:DefinedTerm
133 N0c031f92ebff4a298f40613dbab562ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N15391e8e591647f0b5353e0257fd5345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Female
138 rdf:type schema:DefinedTerm
139 N1a126eec81304c31bf94233379749de0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Comorbidity
141 rdf:type schema:DefinedTerm
142 N2cdbd95850df4ab094c7592ad788489c schema:name dimensions_id
143 schema:value pub.1084128065
144 rdf:type schema:PropertyValue
145 N30a8934164b042269a455c88228f9320 schema:volumeNumber 19
146 rdf:type schema:PublicationVolume
147 N47967678f3f34b9bae432d9669f9d63b rdf:first sg:person.0674353541.09
148 rdf:rest N4ddf825f794a4b4daf825264653f5430
149 N4ddf825f794a4b4daf825264653f5430 rdf:first sg:person.01167017526.04
150 rdf:rest N7349d19482da4bdc8370115450cf455f
151 N619c3648d92b4aef93196859ce3fe0c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Retrospective Studies
153 rdf:type schema:DefinedTerm
154 N6311666e3b7b49ec855e86b25c095ea7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Adult
156 rdf:type schema:DefinedTerm
157 N7349d19482da4bdc8370115450cf455f rdf:first sg:person.01245414340.53
158 rdf:rest Nb29d86abd9e649f28013397e1bf9f3fe
159 N76617ae20b144583b9fca89f561eafdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Medicare
161 rdf:type schema:DefinedTerm
162 N8e10de17f7204cfbb7051ed8648ec228 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Recurrence
164 rdf:type schema:DefinedTerm
165 N9164c9593d4d4f93851a363210c09158 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name United States
167 rdf:type schema:DefinedTerm
168 N9a845df2ac0944c8bc15e1252f65dbf2 schema:name pubmed_id
169 schema:value 28333918
170 rdf:type schema:PropertyValue
171 Na263edbd94e94afb8a680e79a0f93b72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Aged
173 rdf:type schema:DefinedTerm
174 Naccdd8f349a8425886bc389d954f580f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Age Factors
176 rdf:type schema:DefinedTerm
177 Nb29d86abd9e649f28013397e1bf9f3fe rdf:first sg:person.0767710632.29
178 rdf:rest rdf:nil
179 Nbea1ece1976f46c2be2009090488f163 schema:name doi
180 schema:value 10.1038/gim.2017.19
181 rdf:type schema:PropertyValue
182 Nd27cd223523b469694164a8e5de712ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Gene Expression Profiling
184 rdf:type schema:DefinedTerm
185 Nfa1d077c374e435bb36bc9cdf91b0c83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Odds Ratio
187 rdf:type schema:DefinedTerm
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
192 schema:name Oncology and Carcinogenesis
193 rdf:type schema:DefinedTerm
194 sg:journal.1119411 schema:issn 1098-3600
195 1530-0366
196 schema:name Genetics in Medicine
197 schema:publisher Springer Nature
198 rdf:type schema:Periodical
199 sg:person.01167017526.04 schema:affiliation grid-institutes:grid.413726.5
200 schema:familyName Berse
201 schema:givenName Brygida
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167017526.04
203 rdf:type schema:Person
204 sg:person.01245414340.53 schema:affiliation grid-institutes:grid.62562.35
205 schema:familyName Coomer
206 schema:givenName Nicole
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245414340.53
208 rdf:type schema:Person
209 sg:person.0674353541.09 schema:affiliation grid-institutes:grid.280807.5
210 schema:familyName Lynch
211 schema:givenName Julie A.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674353541.09
213 rdf:type schema:Person
214 sg:person.0767710632.29 schema:affiliation grid-institutes:grid.62562.35
215 schema:familyName Kautter
216 schema:givenName John
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767710632.29
218 rdf:type schema:Person
219 sg:pub.10.1007/s10549-010-1329-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015355504
220 https://doi.org/10.1007/s10549-010-1329-6
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s40273-013-0115-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036735183
223 https://doi.org/10.1007/s40273-013-0115-9
224 rdf:type schema:CreativeWork
225 sg:pub.10.1038/gim.2012.119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003414597
226 https://doi.org/10.1038/gim.2012.119
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/gim.2013.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051257040
229 https://doi.org/10.1038/gim.2013.5
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/modpathol.2008.54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020816631
232 https://doi.org/10.1038/modpathol.2008.54
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/modpathol.2013.36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041911179
235 https://doi.org/10.1038/modpathol.2013.36
236 rdf:type schema:CreativeWork
237 grid-institutes:grid.280807.5 schema:alternateName Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA
238 schema:name Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA
239 RTI International, Waltham, Massachusetts, USA
240 rdf:type schema:Organization
241 grid-institutes:grid.413726.5 schema:alternateName Veterans Health Administration, Bedford, Massachusetts, USA
242 schema:name Boston University School of Medicine, Boston, Massachusetts, USA
243 RTI International, Waltham, Massachusetts, USA
244 Veterans Health Administration, Bedford, Massachusetts, USA
245 rdf:type schema:Organization
246 grid-institutes:grid.62562.35 schema:alternateName RTI International, Research Triangle Park, North Carolina, USA
247 RTI International, Waltham, Massachusetts, USA
248 schema:name RTI International, Research Triangle Park, North Carolina, USA
249 RTI International, Waltham, Massachusetts, USA
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...